Dr. Prasanth Manohar, Ph.D., – Page 51 – PHAGElogist

Belgium’s new brand of phage therapy

Belgium’s new brand of phage therapy We’ve talked about emergency/compassionate phage therapy cases, where patients get phages in the case of life-threatening, antibiotic-resistant infections. This requires new paperwork and federal approval…

Bacteriophage Market – Analysis On Trends & Need 2028 | Fixed-Phage Limited, EnBiotix, Inc.

The Research Report on “Bacteriophage Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 – 2028”, issued by TMR Research, includes a detailed qualitative and quantitative analysis of…

Superbugs: How the world’s rivers have become flooded with antibiotics

Antibiotics have colonised the world's rivers and are thought to be fuelling the growing global problem of antimicrobial resistance, according to the first worldwide study of its kind. Describing the findings as "eye-opening and worrying", …

Where we are heading with superbugs and antibiotic crisis?

Antibiotic resistance to superbugs — ‘We’re reaching breaking point and running out of options’. The number of patients with life-threatening conditions who have failed to respond to antibiotics has risen…

“SuperBug Team” to fight antibiotic resistant infections using ‘Phage therapy’

https://superbugdocs.com/ About our group: We are a group of MDs and PhDs who are committed to delivering cGMP and FDA approved solutions to stop the senseless pain, suffering and death from…

Armata Pharmaceuticals- Successful Adjunctive Phage Treatment in Cystic Fibrosis Patient

Armata's bacteriophage, AP-PA01, used to treat multidrug-resistant Pseudomonas aeruginosa infection Paper appears in the peer-reviewed journal Infection. Armata Pharmaceuticals, Inc. (NYSE American: ARMP), a clinical-stage biotechnology company focused on precisely…

ContraFect – Novel Phage Lysins for MRSA

About ContraFect: ContraFect is a biotechnology company focused on discovering and developing differentiated biologic therapies for life-threatening, drug-resistant infectious diseases, particularly those treated in hospital settings. An estimated 700,000 deaths…

If not phage, what about lysins?

https://www.contrafect.com/ https://www.rockefeller.edu/our-scientists/heads-of-laboratories/1160-vincent-a-fischetti/ Lysin Mechanism of Action Lysins are a new class of agents for the treatment of bacterial infections. Lysins are recombinant enzymatic proteins derived from bacteriophage that directly digest…

‘Another Day, another phage therapy treatment, another success story’ – Liver transplant baby saved by “trained” virus at Saint-Luc hospital

Doctors at the Saint-Luc university hospital in Brussels have saved the life of a 13-month-old baby using a revolutionary technique thought to be a world first.The baby was born with…

“SHE-RO” book launch, that’s Women empowerment

23 May 201923 May 2019

Thank you for the honor and let your glory spread across with much more writing. Looking forward Author. ... You are an inspiration "shimmering light of pure energy"... .